Literature DB >> 8346214

Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene.

G L Prasad1, R A Fuldner, H L Cooper.   

Abstract

Synthesis of certain members of the tropomyosin family of microfilament-associated proteins is suppressed in fibroblasts neoplastically transformed by a number of retroviral oncogenes, by transforming growth factor alpha, and by chemical mutagens. To test whether tropomyosin suppression is a required event in neoplastic transformation, expression of one of two suppressed tropomyosins in NIH 3T3 mouse cells transformed by the ras oncogene was restored by retrovirally mediated cDNA transfer. Cells expressing the inserted cDNA showed partial restoration of microfilament bundle formation (which is typically deranged in transformed cells) together with increased cytoplasmic spreading. More importantly, they lost anchorage-independent growth capability, and the onset of tumor growth in athymic mice was delayed. When tumors arose they no longer expressed the inserted cDNA. These observations support the conclusion that tropomyosin suppression is a necessary event for the expression of components of the transformed phenotype, particularly with respect to anchorage-independent growth and tumorigenesis, which correlate closely with neoplastic potential. This potentially reversible requirement may link different initial events produced by a variety of oncogenic modalities to a common pathway leading to neoplastic growth.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8346214      PMCID: PMC47071          DOI: 10.1073/pnas.90.15.7039

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  A cDNA encoding a muscle-type tropomyosin cloned from a human epithelial cell line: identity with human fibroblast tropomyosin TM1.

Authors:  G L Prasad; S Meissner; D G Sheer; H L Cooper
Journal:  Biochem Biophys Res Commun       Date:  1991-06-28       Impact factor: 3.575

2.  A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs.

Authors:  G P Zambetti; D Olson; M Labow; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 3.  The molecular basis for tropomyosin isoform diversity.

Authors:  J P Lees-Miller; D M Helfman
Journal:  Bioessays       Date:  1991-09       Impact factor: 4.345

Review 4.  Retroviral oncogenes: interrelationships between neoplastic transformation and cell differentiation.

Authors:  N Auersperg; C Roskelley
Journal:  Crit Rev Oncog       Date:  1991

5.  The effect of antisense p120 construct on p120 expression and cell proliferation in human breast cancer MCF-7 cells.

Authors:  Y Saijo; L Perlaky; B C Valdez; R K Busch; D Henning; W W Zhang; H Busch
Journal:  Cancer Lett       Date:  1993-02       Impact factor: 8.679

6.  Stimulation of cell division and fibroblast focus formation by antisense repression of retinoblastoma protein synthesis.

Authors:  M Strauss; S Hering; A Lieber; G Herrmann; B E Griffin; W Arnold
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

7.  Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line.

Authors:  P F Robbins; J A Kantor; M Salgaller; P H Hand; P D Fernsten; J Schlom
Journal:  Cancer Res       Date:  1991-07-15       Impact factor: 12.701

8.  Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts.

Authors:  R Narayanan; K G Lawlor; R Q Schaapveld; K R Cho; B Vogelstein; P Bui-Vinh Tran; M P Osborne; N T Telang
Journal:  Oncogene       Date:  1992-03       Impact factor: 9.867

9.  Suppression of tumorigenicity in simian virus 40-transformed 3T3 cells transfected with alpha-actinin cDNA.

Authors:  U Glück; D J Kwiatkowski; A Ben-Ze'ev
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

10.  Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA.

Authors:  J L Rodríguez Fernández; B Geiger; D Salomon; I Sabanay; M Zöller; A Ben-Ze'ev
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

View more
  52 in total

1.  Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts.

Authors:  Geraldine Pawlak; David M Helfman
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

2.  Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin.

Authors:  Janiel M Shields; Heena Mehta; Kevin Pruitt; Channing J Der
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  The 3'-untranslated regions of cytoskeletal muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein kinase PKR.

Authors:  Jean M Nussbaum; Shobha Gunnery; Michael B Mathews
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

4.  The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin.

Authors:  Jing-Chuan Zhang; Fernando Donate; Xiaoping Qi; Nicholas P Ziats; Jose C Juarez; Andrew P Mazar; Yuan-Ping Pang; Keith R McCrae
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-26       Impact factor: 11.205

Review 5.  Proteomic dissection of dome formation in a mammary cell line.

Authors:  I Zucchi; R Dulbecco
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

Review 6.  Interior decoration: tropomyosin in actin dynamics and cell migration.

Authors:  Justin G Lees; Cuc T T Bach; Geraldine M O'Neill
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

7.  Specific features of neuronal size and shape are regulated by tropomyosin isoforms.

Authors:  Galina Schevzov; Nicole S Bryce; Rowena Almonte-Baldonado; Josephine Joya; Jim J-C Lin; Edna Hardeman; Ron Weinberger; Peter Gunning
Journal:  Mol Biol Cell       Date:  2005-05-11       Impact factor: 4.138

8.  Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.

Authors:  L R De Vitis; A Tedde; F Vitelli; F Ammannati; P Mennonna; U Bigozzi; E Montali; L Papi
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

9.  Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton.

Authors:  G C Prendergast; J P Davide; S J deSolms; E A Giuliani; S L Graham; J B Gibbs; A Oliff; N E Kohl
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Suppression of glial tumor growth by expression of glial fibrillary acidic protein.

Authors:  M Toda; M Miura; H Asou; I Sugiyama; T Kawase; K Uyemura
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.